EE261 Economic Evaluation of Dupilumab Versus Standard of Care for the Treatment of Adult Patients With Moderate-to-Severe Prurigo Nodularis in the United States
Abstract
Authors
J Tavi D Bahloul A Kuznik RB Thomas C Knight N Manga S Sullivan